Webinar: A Real World Look at New Hepatitis Delta Prevalence Data in the U.S.
Wednesday, June 28th 12:00 PDT/ 2:00 CDT/ 3:00 EDT
Since the discovery of the hepatitis delta virus (HDV) in 1977, research and testing has advanced slowly, contributing to sparse prevalence data and limited awareness, especially in the U.S. Renewed scientific interest and recent clinical trial research has paved the way for new prevalence studies and a better understanding of the true burden of HDV on hepatitis B patients. Join us as Eduardo Martins, M.D., DPhil, provides a closer look at newly released U.S. prevalence data, which reveals rising rates and hotspots of HDV across the U.S. The webinar will provide an overview of HDV and explain its growing footprint within the U.S., and discuss the value of HDV testing.
Register at this link.
*Be sure to register early, space is limited. A confirmation email with information on how to join the webinar will be sent to you after you register.
Eduardo Martins, M.D., DPhil
Senior Vice President, Liver and Infectious Diseases; Eiger Biopharmaceuticals